版本:
中国

BRIEF-InSphero announces agreement with Pfizer to develop novel assays for predicting drug-induced liver injury

April 27 Insphero AG

* Insphero announces agreement with Pfizer to develop novel assays for predicting drug-induced liver injury

* Insphero AG - entered into agreement with Pfizer Inc to develop novel predictive toxicology assay using insphero 3d insight human liver microtissues

* Insphero AG - agreement commences in April 2017 and involves insphero scientists in USA, Switzerland facilities, with input from Pfizer scientists Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐